期刊文献+

微小RNA调控肿瘤细胞耐药机制形成的研究进展 被引量:1

Research progress of microRNA regulating the formation of tumor cell resistance mechanism
原文传递
导出
摘要 目前,多数恶性肿瘤常规化疗效果差、预后不良,是困扰临床工作的重要难题,而肿瘤细胞耐药性的产生是导致化疗失败的重要原因之一.经过积极化疗后,残存肿瘤干细胞耐药性的存在,可导致肿瘤细胞对多数化学药物敏感性降低,引起肿瘤复发、转移,最终危及患者生命.肿瘤细胞耐药性的形成机制较为复杂,涉及的信号分子及信号通路相对较多,其具体机制尚未完全阐明.根据目前相关研究,微小RNA(miRNA)与肿瘤耐药性的形成高度相关.miRNA通过对耐药机制进行靶向调节,对减少肿瘤细胞耐药性形成起着非常重要的作用.笔者拟就目前miRNA调控肿瘤细胞耐药机制形成的研究进展进行综述. At present,the poor prognosis of conventional chemotherapy for most malignant tumors is an important problem for clinical work,but the tumor cell resistance is one of the important reasons for the failure of chemotherapy.The existence of tumor stem cell resistance ean cause tumor cells to reduce the sensitivity of most chemical drugs after a positive chemotherapy,the recurrence and metastasis of tumor can ultimately endanger the patient's life.The formation mechanism of drug resistance of tumor cells is complex.And there are many signal molecules and signal transduction pathways related with the formation mechanism of drug resistance,but the concrete mechanism is not yet fully clarified.MicroRNA (miRNA) and the formation of tumor drug resistance are highly correlated according to relevant researches.MiRNA can targetedly regulate drug resistance mechanism and plays a very important role in reducing drug resistance of tumor cells.This article intends to review the research advances of the formation mechanism of miRNA resistant tumor cells.
出处 《国际输血及血液学杂志》 CAS 2015年第3期266-269,共4页 International Journal of Blood Transfusion and Hematology
基金 江苏省“六大高峰人才”项目(2012-WSW-035)
关键词 微RNAS 负向调控 肿瘤细胞 抗药性 肿瘤 MicroRNAs Negative regulation Tumor cell Drug resistance, neoplasm
  • 相关文献

参考文献29

  • 1Farh KK, Grimson A, Jan C, et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution[J]. Science, 2005, 310(5755):1817-1821.
  • 2Landau DA, Slack FJ. MicroRNAs in mutagenesis, genomic instability and DNA repair[J]. Semin Oncol, 2011, 38(6)..743- 751.
  • 3Zheng T, Wang J, Chen X, et al. Role of microRNA in anticancer drug resistance[J]. Int J Cancer, 2010, 126(1): 2- 10.
  • 4Moskwa P, Buffa FM, Pan Y, et al. miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors[J]. Mol Cell, 2011, 41(2): 210-220.
  • 5Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCAI[J]. Science, 1994, 266(5182): 66-71.
  • 6Sun C, Li N, Yang Z, et al. miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition[J]. J Natl Cancer Inst, 2013, 105(22): 1750-1758.
  • 7van Jaarsveld MT, Wouters MD, Boersma AW, et al. DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity[J]. Mol Oncol, 2014, 8(3): 458- 468.
  • 8Tsang TY, Tang WY, Chan JY, et al. P-glycoprotein enhances radiation-induced apoptotic cell death through the regulation of miR-16 and Bcl-2 expressions in bepatocellular carcinoma cells [J]. Apoptosis, 2011, 16(5): 524-535.
  • 9Nakazawa K, Dashzeveg N, Yoshida K. Tumor suppressor p53 induces miR-1915 processing to inhibit Bcl-2 in the apoptotic response to DNA damage[J]. FEBS J, 2014, 281(13) : 2937- 2944.
  • 10Tan X, Peng J, Fu Y, et al. miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple negative breast cancer[J]. Breast Cancer Res, 2014, 16 (5) : 435.

二级参考文献47

  • 1Piccart MJ,Bertelsen K,James K,et al.Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer; three-year results.J Natl Cancer Inst,2000,92:699-708.
  • 2Barbarotto E,Schmittgen TD,Calin GA.MicroRNAs and cancer:profile,profile,profile.Int J Cancer,2008,122:969-977.
  • 3Zhu H,Wu H,Liu X,et al.Role of MicroRNA miR-27a and miR-451 in the regulation of MDRl/P-glycoprotein expression in human cancer cells.Biochem Pharmacol,2008,76:582-588.
  • 4Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method.Methods,2001,25:402408.
  • 5Si ML,Zhu S,Wu H,et al.miR-21-mediated tumor growth.Oncogene,2007,26:2799-2803.
  • 6Kovalchuk 0,Filkowski J,Meservy J,et al.Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.Mol Cancer Ther,2008,7:2152-2159.
  • 7D'Orazi G,Cecchinelli B,Bruno T,et al.Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.Nat Cell Biol,2002,4:11-19.
  • 8Liu L,Ning X,Sun L,et al.Hypoxia-inducible factor-lα contributes to hypoxia-induced chemoresistance in gastric cancer.Cancer Sci,2008,99:121-128.
  • 9Puca R,Nardinocchi L,Pistritto G,et al.Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.Cynecol Oncol,2008,109:403410.
  • 10Slezak-Prochazka I,Durmus S,Kroesen BJ,et al.MicroRNAs,macrocontrol:regulation of miRNA processing[J].RNA,2010,16(6):1087-1095.

共引文献11

同被引文献16

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部